🟢 Neurosense Therapeutics is trading 8.3% up today as it rebounds from a sharp multi-day selloff

Neurosense Therapeutics is trading at $0.52 (up 8.3%) in after-hours trading, rebounding from a sharp decline to a $0.48 close on July 29, 2026.

• The stock had faced several days of weakness tied to broader biotech sector pressure and ongoing Nasdaq compliance concerns.
• With no fresh company-specific news or earnings reported after the bell, the move suggests short-term bargain hunting and thin after-hours liquidity rather than a new fundamental catalyst.